SPDR S&P Biotech ETF $XBI Shares Sold by HBK Sorce Advisory LLC

HBK Sorce Advisory LLC reduced its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,441 shares of the exchange traded fund’s stock after selling 351 shares during the period. HBK Sorce Advisory LLC’s holdings in SPDR S&P Biotech ETF were worth $451,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in the company. Investment Partners Asset Management Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 4.0% in the 2nd quarter. Investment Partners Asset Management Inc. now owns 3,257 shares of the exchange traded fund’s stock valued at $270,000 after purchasing an additional 125 shares during the period. Compass Ion Advisors LLC lifted its stake in shares of SPDR S&P Biotech ETF by 3.9% in the 2nd quarter. Compass Ion Advisors LLC now owns 3,727 shares of the exchange traded fund’s stock valued at $309,000 after purchasing an additional 140 shares during the period. McAdam LLC lifted its stake in shares of SPDR S&P Biotech ETF by 5.1% in the 2nd quarter. McAdam LLC now owns 3,273 shares of the exchange traded fund’s stock valued at $271,000 after purchasing an additional 159 shares during the period. First Heartland Consultants Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 2.7% in the 1st quarter. First Heartland Consultants Inc. now owns 6,344 shares of the exchange traded fund’s stock valued at $514,000 after purchasing an additional 168 shares during the period. Finally, Calton & Associates Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 3.2% in the 1st quarter. Calton & Associates Inc. now owns 5,662 shares of the exchange traded fund’s stock valued at $459,000 after purchasing an additional 175 shares during the period.

SPDR S&P Biotech ETF Price Performance

XBI opened at $112.71 on Friday. The firm has a fifty day moving average price of $100.28 and a 200 day moving average price of $89.18. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $113.21. The stock has a market cap of $6.87 billion, a P/E ratio of 11.47 and a beta of 0.93.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.